Bloodstream Infection
50
7
10
19
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.0%
4 terminated out of 50 trials
82.6%
-3.9% vs benchmark
8%
4 trials in Phase 3/4
21%
4 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (50)
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
Next Generation Pathogen Sequencing for Prediction of Adverse Events
The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia
Advanced Dressings for CVC Infection Prevention in PICU
Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples
European Prospective Bloodstream Infection Cohort
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
Optimising TREATment for Severe Gram-Negative Bacterial Infections
The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia
Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit
Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment
ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs
The Role of NK Cells to Detect Blood Infection in ALL.
Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections